Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
LivaNova PLC | President, Global Epilepsy | Ordinary Shares | 9.56K | $535K | $55.94 | Mar 30, 2024 | Direct |
LivaNova PLC | President, Global Epilepsy | Restricted Stock Units | 4.92K | $269K | $54.81 | Mar 30, 2024 | Direct |
LivaNova PLC | President, Global Epilepsy | Stock Appreciation Rights | 10.7K | Mar 30, 2024 | Direct | ||
LivaNova PLC | President, Global Epilepsy | Performance Stock Units | 4.92K | Mar 30, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LIVN | LivaNova PLC | Mar 30, 2024 | 14 | -$204K | 4 | Apr 2, 2024 | President, Global Epilepsy |
LIVN | LivaNova PLC | Mar 1, 2024 | 0 | $0 | 3 | Mar 11, 2024 | President, Global Epilepsy |